Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells

Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells

Bone destruction induced by the metastasis of breast cancer cells is a frequent complication that is caused by the interaction between cancer cells and bone cells. Receptor activator of nuclear factor kappa-B ligand (RANKL) and the endogenous soluble RANKL inhibitor, osteoprotegerin (OPG), directly...

Full description

Bibliographic Details
Main Authors: Lee, Sun Kyoung, Park, Kwang-Kyun, Kim, Ki Rim, Kim, Hyun-Jeong, Chung, Won-Yoon
Format: Online
Language:English
Published: Korean Society of Cancer Prevention 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699756/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699756/

Similar Items